Cathie Wood Veracyte, Inc. Transaction History

Ark Investment Management LLC

$14 Billion
Q1 2024

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Veracyte, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 7,042,783 shares of VCYT stock, worth $161 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

7,042,783

Previous 7,655,603 8.0%

Holding current value

$161 Million

Previous $211 Million 25.9%

% of portfolio

1.11%

Previous 1.26%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$21.0 - $29.1 $12.9 Million - $17.8 Million	-612,820 Reduced 8.0%	7,042,783 $156 Million
Q4 2023 Jan 17, 2024	BUY	$19.72 - $28.68 $1.22 Million - $1.78 Million	62,011 Added 0.82%	7,655,603 $211 Million
Q3 2023 Oct 18, 2023	SELL	$22.33 - $29.92 $5.24 Million - $7.02 Million	-234,700 Reduced 3.0%	7,593,592 $170 Million
Q2 2023 Jul 10, 2023	SELL	$20.96 - $26.99 $12.2 Million - $15.7 Million	-580,814 Reduced 6.91%	7,828,292 $199 Million
Q1 2023 Apr 17, 2023	BUY	$20.58 - $27.89 $2.24 Million - $3.04 Million	108,865 Added 1.31%	8,409,106 $188 Million

Q4 2022 Jan 24, 2023	SELL	$15.31 - $29.94 $12 Million - $23.4 Million	-781,122 Reduced 8.6%	8,300,241 $0
Q3 2022 Oct 17, 2022	BUY	$16.58 - $27.9 $3.73 Million - $6.28 Million	225,118 Added 2.54%	9,081,363 $151 Million
Q2 2022 Jul 11, 2022	BUY	$15.45 - $29.52 $1.55 Million - $2.96 Million	100,221 Added 1.14%	8,856,245 $156 Million
Q1 2022 Apr 19, 2022	BUY	$21.94 - $42.51 $11.7 Million - $22.7 Million	533,743 Added 6.49%	8,756,024 $241 Million
Q4 2021 Jan 28, 2022	BUY	$36.09 - $53.79 $44.8 Million - $66.8 Million	1,242,080 Added 17.79%	8,222,281 $339 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $10.4 Million - $15.4 Million	290,938 Added 4.35%	6,980,201 $324 Million
Q2 2021 Aug 05, 2021	SELL	$32.94 - $56.62 $30.6 Million - $52.5 Million	-928,024 Reduced 12.18%	6,689,263 $267 Million
Q1 2021 May 13, 2021	SELL	$44.47 - $81.38 $62.7 Million - $115 Million	-1,410,540 Reduced 15.62%	7,617,287 $409 Million
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $65.3 Million - $124 Million	2,009,057 Added 28.62%	9,027,827 $442 Million
Q3 2020 Oct 30, 2020	BUY	$26.73 - $35.67 $52.3 Million - $69.7 Million	1,954,977 Added 38.61%	7,018,770 $228 Million
Q2 2020 Aug 11, 2020	BUY	$19.49 - $28.11 $35 Million - $50.5 Million	1,797,934 Added 55.05%	5,063,793 $131 Million
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $7.7 Million - $14.4 Million	477,423 Added 17.12%	3,265,859 $79.4 Million
Q4 2019 Jan 31, 2020	BUY	$20.78 - $29.99 $4.27 Million - $6.17 Million	205,638 Added 7.96%	2,788,436 $77.9 Million
Q3 2019 Nov 12, 2019	SELL	$23.87 - $30.93 $10.8 Million - $14 Million	-453,855 Reduced 14.95%	2,582,798 $62 Million
Q2 2019 Jul 30, 2019	SELL	$22.1 - $28.56 $9.34 Million - $12.1 Million	-422,420 Reduced 12.21%	3,036,653 $86.6 Million
Q1 2019 May 13, 2019	SELL	$12.0 - $25.76 $410,184 - $880,528	-34,182 Reduced 0.98%	3,459,073 $86.5 Million
Q4 2018 Feb 01, 2019	SELL	$9.15 - $14.85 $4.1 Million - $6.65 Million	-447,549 Reduced 11.36%	3,493,255 $43.9 Million
Q3 2018 Nov 07, 2018	BUY	$9.55 - $12.64 $1.72 Million - $2.28 Million	180,145 Added 4.79%	3,940,804 $37.6 Million
Q2 2018 Aug 07, 2018	BUY	$5.39 - $9.66 $5.12 Million - $9.17 Million	949,365 Added 33.77%	3,760,659 $35.1 Million
Q1 2018 May 14, 2018	BUY	$5.44 - $6.97 $7.67 Million - $9.82 Million	1,409,030 Added 100.48%	2,811,294 $15.6 Million
Q4 2017 Feb 12, 2018	BUY	$6.05 - $9.37 $5.53 Million - $8.56 Million	913,926 Added 187.15%	1,402,264 $9.16 Million
Q3 2017 Nov 09, 2017	BUY	$7.81 - $8.77 $2.54 Million - $2.85 Million	325,318 Added 199.56%	488,338 $4.28 Million
Q2 2017 Aug 11, 2017	BUY	N/A	103,157 Added 172.32%	163,020 $1.36 Million
Q1 2017 May 15, 2017	BUY	N/A	14,512 Added 32.0%	59,863 $550,000
Q4 2016 Feb 13, 2017	BUY	N/A	45,351	45,351 $351,000

Others Institutions Holding VCYT

# of Institutions

257

Shares Held

81.7M

Call Options Held

43K

Put Options Held

82K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.64B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account